Craft

Champions Oncology

Stock Price

$4

2024-10-29

Market Capitalization

$54.1 M

2024-10-29

Revenue

$56.9 M

FY, 2025

Champions Oncology Summary

Company Summary

Overview
Champions Oncology is an oncology research company that provides drug development solutions for the pharmaceutical industry. It offers Ex Vivo, an oncology data platform that supports programs from target to biomarker discovery. The company also provides in-vivo modeling, preclinical research, and clinical testing services.
Type
Public
Status
Active
Founded
2007
HQ
Hackensack, NJ, US | view all locations
Website
https://www.championsoncology.com
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

Key People

  • Ronnie Morris

    Ronnie Morris, Chief Executive Officer and Director

  • Philip P. Breitfeld
  • David Miller

    David Miller, Chief Financial Officer

  • Michael Ritchie

    Michael Ritchie, Chief Commercial Officer

LocationsView all

4 locations detected

  • Hackensack, NJ HQ

    United States

    One University Plaza, Suite 307

  • Rockville, MD

    United States

    1330 Piccard Drive, Suite 025 & Suite 104

  • Rehovot, Tel Aviv District

    Israel

    4 Oppenheimer Street, Ha’ogen Building B

  • Milan, Lombardia

    Italy

    Via L. Ariosto 21, 1st Floor

Champions Oncology Financials

Summary Financials

Revenue (Q3, 2026)
$16.6M
Gross profit (Q3, 2026)
$7.7M
Net income (Q3, 2026)
($279.0K)
Cash (Q3, 2026)
$7.1M
EBIT (Q3, 2026)
($276.0K)
Enterprise value
$51.9M

Footer menu